Table: Kobayashi Pharmaceutical -Q1 group results

Kobayashi Pharmaceutical

27/04/2021 07:00

Apr 27 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2021        Mar 31, 2020     Dec 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             30.27               31.91           156.00    
                 (-5.1 pct)          (+0.7 pct)       (+3.6 pct)  
  Operating          4.69                4.88            26.00    
                 (-3.8 pct)          (-5.3 pct)       (+0.2 pct)  
  Recurring          5.19                5.04            27.80    
                 (+3.0 pct)          (-3.4 pct)       (+0.3 pct)  
  Net                3.63                3.74            19.50    
                 (-3.1 pct)          (+1.6 pct)       (+1.5 pct)  
  EPS             46.42 yen           47.89 yen       249.48 yen  
  Ann Div                             77.00 yen        79.00 yen  
  -Q2 div                             34.00 yen        35.00 yen  
  -Q4 div                             43.00 yen        44.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T